Fabtech technologies has responded to clarification requests from stock exchanges regarding recent movements in its share price. The company addressed queries from both the National Stock Exchange of India Limited and BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Company's Official Response

In its official communication dated March 11, 2026, the company categorically stated that there is no pending information or announcement that could be considered price sensitive and might have led to significant movement in share price behavior. The management emphasized that the observed price movements are purely market driven.

Regulatory Compliance Assurance

Executive Director Hemant Mohan Anavkar, holding DIN 00150776, signed the response on behalf of the company. The communication reaffirmed the company's commitment to maintaining transparency with stock exchanges and ensuring timely disclosure of all material information.

The company assured that it continues to inform stock exchanges of all information and announcements required to be disclosed under applicable regulations, as and when required. This response demonstrates the company's adherence to regulatory compliance and transparency standards.

Exchange Communication Details

The clarification was submitted to both major stock exchanges where the company's shares are listed. The response addressed specific queries raised under the provisions of Regulation 30, which mandates companies to disclose material events and information that could impact share prices.

The company requested both exchanges to take the clarification on record, completing the regulatory requirement for responding to price movement queries.

Fabtech Technologies Limited has submitted its investor presentation to the National Stock Exchange of India Limited and BSE Limited for the upcoming Investors/Analysts Meeting at CVOCA Investocraft 2026. The presentation was filed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, on February 27, 2026.

Meeting Details and Regulatory Compliance

The investor interaction is scheduled for February 28, 2026, from 8:30 a.m. (IST) onwards at Sahara Star, Vile Parle, Mumbai. The company has structured this as a group meeting with investors to be conducted in physical mode.

The notification was signed by Hemant Mohan Anavkar, Executive Director with DIN: 00150776. The company has emphasized that all discussions will be based on publicly available information only, with no unpublished price-sensitive information intended to be shared.

Strategic Market Positioning

The investor presentation positions Fabtech Technologies as India's Global Life Sciences Infrastructure Platform, focusing on engineering medicinal sovereignty across continents. The company highlights its role in the 15-year lifescience infrastructure buildout across GCC, Middle East & Africa and surrounding nations.

Market Opportunity and Financial Highlights

The presentation outlines a significant Total Addressable Market (TAM) across three key regions. The GCC market shows an estimated pharma capex of USD 40-50 billion for 2025-2040, driven by Saudi Vision 2030, UAE biotech initiatives, and localization mandates.

The company reports a current order book of approximately ₹926 crore as of January 31, 2026. Fabtech Technologies aims to improve its conversion rate from 10% to 20% post-European acquisition, which would double the hit rate on the same lead base.

Execution Capabilities and Strategic Presence

The presentation emphasizes Fabtech's integrated capabilities across process engineering, HVAC and containment systems, water systems, and in-house manufacturing leverage. The company operates through an ecosystem of subsidiaries including Fabtech Technologies LLC (UAE), TSA, and other specialized entities.

Fabtech Technologies has established benchmark projects including the first Egyptian flu vaccine project, largest IV solution facility in Saudi Arabia, and UAE's only USFDA approved facility. These projects create regulatory credibility and reference advantages in the competitive landscape.